NCAM1 and myalgic encephalomeyelitis/chronic fatigue syndrome: Although ME/CFS patients showed a trend towards lower levels of effector CD8+ T cells and CD56+ T cells and higher levels of natural Treg cells, consistent with the differences found in our 2013 study, on this occasion, no significant differences could be established between groups.